(ENB) Enbridge - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA29250N1050
Stock:
Total Rating 60
Risk 50
Buy Signal 0.29
| Risk 5d forecast | |
|---|---|
| Volatility | 17.1% |
| Relative Tail Risk | 3.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.55 |
| Alpha | 29.26 |
| Character TTM | |
|---|---|
| Beta | 0.105 |
| Beta Downside | 0.216 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.86% |
| CAGR/Max DD | 0.99 |
EPS (Earnings per Share)
Revenue
Description: ENB Enbridge
Enbridge Inc., together with its subsidiaries, operates as an energy infrastructure company. The company operates through four segments: Liquids Pipelines, Gas Transmission, Gas Distribution and Storage, and Renewable Power Generation. The Liquids Pipelines segment operates pipelines and related terminals to transport, store, and export various grades of crude oil and other liquid hydrocarbons in Canada and the United States. This segment also provides physical commodity marketing and logistical services, and crude oil marketing services. The Gas Transmission segment invests in natural gas pipelines and gathering and processing facilities in Canada and the United States. The Gas Distribution and Storage segment is involved in natural gas utility operations serving residential, commercial, and industrial customers in Ontario, as well as natural gas distribution activities in Quebec. The Renewable Power Generation segment operates wind, solar, geothermal, waste heat recovery, and transmission assets in North America. The company was formerly known as IPL Energy Inc. and changed its name to Enbridge Inc. in October 1998. Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 7.49b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.40 > 1.0 |
| NWC/Revenue: -27.93% < 20% (prev -19.91%; Δ -8.02% < -1%) |
| CFO/TA 0.06 > 3% & CFO 12.27b > Net Income 7.49b |
| Net Debt (104.16b) to EBITDA (19.74b): 5.28 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -1.86% < -2% |
| Gross Margin: 35.13% > 18% (prev 0.36%; Δ 3477 % > 0.5%) |
| Asset Turnover: 29.79% > 50% (prev 24.42%; Δ 5.37% > 0%) |
| Interest Coverage Ratio: 2.78 > 6 (EBITDA TTM 19.74b / Interest Expense TTM 5.06b) |
Altman Z'' -0.05
| A: -0.08 (Total Current Assets 2.80b - Total Current Liabilities 21.00b) / Total Assets 218.47b |
| B: -0.10 (Retained Earnings -21.28b / Total Assets 218.47b) |
| C: 0.06 (EBIT TTM 14.08b / Avg Total Assets 218.72b) |
| D: 0.36 (Book Value of Equity 55.27b / Total Liabilities 152.55b) |
| Altman-Z'' Score: -0.05 = B |
Beneish M -2.96
| DSRI: 0.80 (Receivables 7.17b/7.38b, Revenue 65.17b/53.47b) |
| GMI: 1.03 (GM 35.13% / 36.03%) |
| AQI: 1.13 (AQ_t 0.38 / AQ_t-1 0.34) |
| SGI: 1.22 (Revenue 65.17b / 53.47b) |
| TATA: -0.02 (NI 7.49b - CFO 12.27b) / TA 218.47b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of ENB shares?
As of March 01, 2026, the stock is trading at USD 53.14 with a total of 7,668,375 shares traded.
Over the past week, the price has changed by +3.14%, over one month by +12.11%, over three months by +10.37% and over the past year by +34.76%.
Over the past week, the price has changed by +3.14%, over one month by +12.11%, over three months by +10.37% and over the past year by +34.76%.
Is ENB a buy, sell or hold?
Enbridge has received a consensus analysts rating of 3.65.
Therefor, it is recommend to hold ENB.
- StrongBuy: 8
- Buy: 2
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the ENB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.9 | -4.2% |
| Analysts Target Price | 50.9 | -4.2% |
ENB Fundamental Data Overview February 27, 2026
P/E Trailing = 22.234
P/E Forward = 21.7865
P/S = 1.7486
P/B = 2.5739
P/EG = 1.8363
Revenue TTM = 65.17b USD
EBIT TTM = 14.08b USD
EBITDA TTM = 19.74b USD
Long Term Debt = 98.96b USD (from longTermDebt, last quarter)
Short Term Debt = 6.29b USD (from shortTermDebt, last quarter)
Debt = 105.25b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 104.16b USD (from netDebt column, last quarter)
Enterprise Value = 218.16b USD (114.00b + Debt 105.25b - CCE 1.09b)
Interest Coverage Ratio = 2.78 (Ebit TTM 14.08b / Interest Expense TTM 5.06b)
EV/FCF = 70.26x (Enterprise Value 218.16b / FCF TTM 3.10b)
FCF Yield = 1.42% (FCF TTM 3.10b / Enterprise Value 218.16b)
FCF Margin = 4.76% (FCF TTM 3.10b / Revenue TTM 65.17b)
Net Margin = 11.49% (Net Income TTM 7.49b / Revenue TTM 65.17b)
Gross Margin = 35.13% ((Revenue TTM 65.17b - Cost of Revenue TTM 42.27b) / Revenue TTM)
Gross Margin QoQ = 33.06% (prev 42.02%)
Tobins Q-Ratio = 1.00 (Enterprise Value 218.16b / Total Assets 218.47b)
Interest Expense / Debt = 1.22% (Interest Expense 1.28b / Debt 105.25b)
Taxrate = 13.23% (324.7m / 2.45b)
NOPAT = 12.22b (EBIT 14.08b * (1 - 13.23%))
Current Ratio = 0.13 (Total Current Assets 2.80b / Total Current Liabilities 21.00b)
Debt / Equity = 1.69 (Debt 105.25b / totalStockholderEquity, last quarter 62.33b)
Debt / EBITDA = 5.28 (Net Debt 104.16b / EBITDA 19.74b)
Debt / FCF = 33.55 (Net Debt 104.16b / FCF TTM 3.10b)
Total Stockholder Equity = 60.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.42% (Net Income 7.49b / Total Assets 218.47b)
RoE = 12.34% (Net Income TTM 7.49b / Total Stockholder Equity 60.71b)
RoCE = 8.82% (EBIT 14.08b / Capital Employed (Equity 60.71b + L.T.Debt 98.96b))
RoIC = 7.55% (NOPAT 12.22b / Invested Capital 161.77b)
WACC = 3.78% (E(114.00b)/V(219.25b) * Re(6.30%) + D(105.25b)/V(219.25b) * Rd(1.22%) * (1-Tc(0.13)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 1.59%
[DCF] Terminal Value 85.57% ; FCFF base≈4.34b ; Y1≈4.03b ; Y5≈3.68b
[DCF] Fair Price = 3.06 (EV 110.83b - Net Debt 104.16b = Equity 6.67b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow -8.97% → 2.90% )
EPS Correlation: -5.18 | EPS CAGR: 1.25% | SUE: 1.25 | # QB: 1
Revenue Correlation: 48.72 | Revenue CAGR: 3.46% | SUE: 1.34 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.96 | Chg7d=+0.012 | Chg30d=+0.010 | Revisions Net=-4 | Analysts=9
EPS current Year (2026-12-31): EPS=2.99 | Chg7d=-0.064 | Chg30d=-0.081 | Revisions Net=-2 | Growth EPS=-0.9% | Growth Revenue=-5.8%
EPS next Year (2027-12-31): EPS=3.21 | Chg7d=-0.061 | Chg30d=-0.089 | Revisions Net=-3 | Growth EPS=+7.4% | Growth Revenue=-2.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = -2.6% (Analyst 0.9% - Implied 3.5%)
P/E Forward = 21.7865
P/S = 1.7486
P/B = 2.5739
P/EG = 1.8363
Revenue TTM = 65.17b USD
EBIT TTM = 14.08b USD
EBITDA TTM = 19.74b USD
Long Term Debt = 98.96b USD (from longTermDebt, last quarter)
Short Term Debt = 6.29b USD (from shortTermDebt, last quarter)
Debt = 105.25b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 104.16b USD (from netDebt column, last quarter)
Enterprise Value = 218.16b USD (114.00b + Debt 105.25b - CCE 1.09b)
Interest Coverage Ratio = 2.78 (Ebit TTM 14.08b / Interest Expense TTM 5.06b)
EV/FCF = 70.26x (Enterprise Value 218.16b / FCF TTM 3.10b)
FCF Yield = 1.42% (FCF TTM 3.10b / Enterprise Value 218.16b)
FCF Margin = 4.76% (FCF TTM 3.10b / Revenue TTM 65.17b)
Net Margin = 11.49% (Net Income TTM 7.49b / Revenue TTM 65.17b)
Gross Margin = 35.13% ((Revenue TTM 65.17b - Cost of Revenue TTM 42.27b) / Revenue TTM)
Gross Margin QoQ = 33.06% (prev 42.02%)
Tobins Q-Ratio = 1.00 (Enterprise Value 218.16b / Total Assets 218.47b)
Interest Expense / Debt = 1.22% (Interest Expense 1.28b / Debt 105.25b)
Taxrate = 13.23% (324.7m / 2.45b)
NOPAT = 12.22b (EBIT 14.08b * (1 - 13.23%))
Current Ratio = 0.13 (Total Current Assets 2.80b / Total Current Liabilities 21.00b)
Debt / Equity = 1.69 (Debt 105.25b / totalStockholderEquity, last quarter 62.33b)
Debt / EBITDA = 5.28 (Net Debt 104.16b / EBITDA 19.74b)
Debt / FCF = 33.55 (Net Debt 104.16b / FCF TTM 3.10b)
Total Stockholder Equity = 60.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.42% (Net Income 7.49b / Total Assets 218.47b)
RoE = 12.34% (Net Income TTM 7.49b / Total Stockholder Equity 60.71b)
RoCE = 8.82% (EBIT 14.08b / Capital Employed (Equity 60.71b + L.T.Debt 98.96b))
RoIC = 7.55% (NOPAT 12.22b / Invested Capital 161.77b)
WACC = 3.78% (E(114.00b)/V(219.25b) * Re(6.30%) + D(105.25b)/V(219.25b) * Rd(1.22%) * (1-Tc(0.13)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 1.59%
[DCF] Terminal Value 85.57% ; FCFF base≈4.34b ; Y1≈4.03b ; Y5≈3.68b
[DCF] Fair Price = 3.06 (EV 110.83b - Net Debt 104.16b = Equity 6.67b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow -8.97% → 2.90% )
EPS Correlation: -5.18 | EPS CAGR: 1.25% | SUE: 1.25 | # QB: 1
Revenue Correlation: 48.72 | Revenue CAGR: 3.46% | SUE: 1.34 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.96 | Chg7d=+0.012 | Chg30d=+0.010 | Revisions Net=-4 | Analysts=9
EPS current Year (2026-12-31): EPS=2.99 | Chg7d=-0.064 | Chg30d=-0.081 | Revisions Net=-2 | Growth EPS=-0.9% | Growth Revenue=-5.8%
EPS next Year (2027-12-31): EPS=3.21 | Chg7d=-0.061 | Chg30d=-0.089 | Revisions Net=-3 | Growth EPS=+7.4% | Growth Revenue=-2.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = -2.6% (Analyst 0.9% - Implied 3.5%)